StockVS

NYSE · Medical Instruments & Supplies · USD

Warby Parker Inc. (WRBY) Stock Analysis

Warby Parker Inc. (WRBY) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

WRBY

$24.35

+$1.06 (+4.55%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare WRBY with… →

WRBY Key Statistics

As of Sep 4, 2026
Trading
Open
$23.00
Previous Close
$23.29
Day's Range
22.84–24.43
52-Week Range
14.96–31.00
Volume
3.05M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.91
Valuation
Market Cap
$3.01B
P/E Ratio
405.83
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
39.61
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.30
EPS (ttm)Profit attributable to each share over the last twelve months.
0.06
Financials (FY)
Revenue (FY)
$871.91M+13.04%
Net Income (FY)
$1.64M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.85%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
108.24M
1-Year Return
−3.94%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
2.97M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

WRBY Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+11.75%
2025−10.00%
2024+71.70%
2023+4.52%
2022−71.03%
2021 (partial year)−14.55%

As of September 4, 2026.

WRBY Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$871.91M$1.64M0.2%
2024$771.32M−$20.39M−2.6%
2023$669.77M−$63.20M−9.4%
2022$598.11M−$110.39M−18.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$871.91M$470.58M−$5.34M$1.64M0.2%
2024$771.32M$426.83M−$30.11M−$20.39M−2.6%
2023$669.77M$365.22M−$72.00M−$63.20M−9.4%
2022$598.11M$341.06M−$111.20M−$110.39M−18.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

WRBY Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricWRBYMedical Instruments & Supplies medianvs median
P/E405.8335.6111.4x the median
P/S ratio3.303.174% above
Profit margin0.85%0.85%0.0 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 7 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Warby Parker Inc. (WRBY) carries a market capitalisation of $3.01B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 2,275 employees.

Over the past 52 weeks the price has ranged from $14.96 to $31.00. The most recent close on file for WRBY is $24.35, dated September 4, 2026. That is +$1.06 (+4.55%) against the previous close. The latest close sits 62.77% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $871.91M. Against the prior fiscal year total of $771.32M, that is a change of +13.04%. The same year closed with net income of $1.64M. Profit margin runs at 0.85%. Earnings per share on a trailing basis come to 0.06.

Across the 4 fiscal years on file, revenue moves from $598.11M in 2022 to $871.91M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 405.83. That is 11.4 times the Medical Instruments & Supplies median of 35.61. The forward P/E on file is 39.61. The price-to-sales ratio is 3.3. On price-to-sales that is 4.06% above the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −3.94%. Measured over 3 years, that is +26.11% a year compounded. Beta against the wider market is reported at 1.91. Annualized volatility over the trailing 4 years is 63.41%.

Growth & Income

The record shows no dividend for WRBY.

So far in 2026 the price is +11.75%. Across the complete calendar years on file, 2024 returned +71.70% and 2022 returned −71.03%. Of the 4 complete calendar years on file, 2 finished higher.

Peer Comparison

Warby Parker Inc. (WRBY) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Warby Parker Inc. WRBY $3.01B 405.8
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Warby Parker Inc. trades at a P/E of 405.8.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Warby Parker Inc.

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Visit website →